Antipsychotic Agents: all 1,683 studies that test it
Page 12 of 17. Open to participants first (95), then studies with results posted, then the rest; newest registration first within each.
- Amisulpride Augmentation in Clozapine-unresponsive SchizophreniaCompletedNCT01246232Phase 4
- Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRICompletedNCT01234454Not applicable
- Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in AdultsCompletedNCT01224067Phase 4
- Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fasting ConditionsCompletedNCT01222975Not applicable
- Bioequivalence Study of Risperidone 1 mg Orally-disintegrating Tablets Under Fed ConditionsCompletedNCT01222923Not applicable
- Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult SubjectsCompletedNCT01217918Phase 1
- Neurophysiologic Changes in Patients With Bipolar DepressionStatus unknownNCT01213121Phase 4
- Paliperidone Palmitate Efficacy and Safety in Bipolar Disorder Complicated by AlcoholismWithdrawnNCT01211704Phase 4
- Quetiapine in Melancholic DepressionCompletedNCT01200901Phase 4
- Effectiveness of Ziprasidone for Patients With SchizophreniaCompletedNCT01198353Phase 4
- Efficacy of Quetiapine XR Versus Placebo as Concomitant Treatment to Mood Stabilizers in the Control of Subsyndromal Symptoms of Bipolar DisorderCompletedNCT01197846Phase 3
- Loxapine in the Management of Restlessness During Mechanical Ventilation WeaningCompletedNCT01193816Phase 4
- Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric HospitalWithdrawnNCT01193166Phase 4
- Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive DisorderWithdrawnNCT01189318Phase 2
- Antipsychotics and Gene Expression in Soft TissuesCompletedNCT01185743Phase 4
- Evaluation of the Efficacy and Safety of Olanzapine for Anorexia Nervosa in Children and AdolescentsTerminatedNCT01184443Phase 3
- Preventing ICU Subsyndromal Delirium Conversion to Delirium With HaloperidolCompletedNCT01174290Phase 4
- Risperidone Treatment In Children With Autism Spectrum Disorder And High Levels Of Repetitive BehaviorCompletedNCT01171937Phase 2
- Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in SchizophreniaCompletedNCT01164059Phase 4
- Effects of Aripiprazole and Haloperidol on Mesolimbic System FunctioningCompletedNCT01161277Phase 4
- Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose MetabolismCompletedNCT01160991Not applicable
- Efficacy and Safety of Paliperidone ER in First Episode PsychosisCompletedNCT01157585Phase 4
- Efficacy and Safety With Ziprasidone in First-episode PsychosisCompletedNCT01157559Phase 4
- Pan European Collaboration on Antipsychotic Naive Schizophrenia (PECANS)CompletedNCT01154829Not applicable
- Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia PatientsCompletedNCT01149577Phase 4
- Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough EmesisTerminatedNCT01148264Phase 2
- Effects of Ketamine and Risperidone on CognitionCompletedNCT01140620Phase 4
- Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed)WithdrawnNCT01124877Phase 3
- Clozapine and Olanzapine Treatment of AggressionCompletedNCT01123408Not applicable
- Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to RisperidoneCompletedNCT01119638Phase 4
- Tolerance and Effect of Antipsychotics in Children and Adolescents With PsychosisCompletedNCT01119014Phase 4
- Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196)WithdrawnNCT01117220Phase 3
- A Study of Paliperidone Blood Concentrations in Patients With Schizophrenia After Administration of Paliperidone PalmitateCompletedNCT01110317Phase 1
- A Drug Interaction Study of Valproic Acid and Paliperidone Extended-Release (ER) in Patients With Schizophrenia, Bipolar I Disorder, or Schizoaffective DisorderCompletedNCT01094249Phase 1
- Aripiprazole and Prolactin StudyCompletedNCT01085383Phase 4
- ARIpiprazole in Anorexia NErvosaStatus unknownNCT01082848Phase 3
- Digoxin Drug-Drug Interaction With Lurasidone HClCompletedNCT01082289Phase 1
- Rifampin Drug-Drug Interaction Study With Lurasidone HClCompletedNCT01082276Phase 1
- Midazolam Drug-Drug Interaction Study With Lurasidone HClCompletedNCT01082263Phase 1
- The Bioequivalence Of Two Different Lurasidone Formulations In PatientsCompletedNCT01082250Phase 1
- RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONECompletedNCT01082146Phase 1
- Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HClCompletedNCT01074632Phase 1
- Lithium Drug-Drug Interaction Study With Lurasidone HClCompletedNCT01074073Phase 1
- Quetiapine XR in Schizophrenic PatientsTerminatedNCT01071135Phase 3
- Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fed ConditionCompletedNCT01064271Phase 1
- Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fasting ConditionCompletedNCT01064232Phase 1
- A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy MenCompletedNCT01060228Phase 1
- Standard Comprehensive Intervention to Treat First-episode SchizophreniaStatus unknownNCT01057849Not applicable
- Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of SchizophreniaCompletedNCT01052389Phase 4
- A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With SchizophreniaCompletedNCT01051531Phase 3
- IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute AgitationCompletedNCT01050478Phase 4
- Heart Rate Changes in Schizophrenic and Bipolar Patients Under the Medication of Aripiprazole and QuetiapineStatus unknownNCT01047215Phase 4
- Efficacy and Safety of Utapine vs. Seroquel in Patients With Bipolar ManiaStatus unknownNCT01043679Phase 4
- Efficacy and Safety of Aripiprazole in First Episode PsychosisCompletedNCT01026584Phase 4
- Identifying Predictors of Response to Antipsychotics Using a Treatment AlgorithmStatus unknownNCT01016145Phase 4
- Ziprasidone in Early Onset Schizophrenia Spectrum DisordersCompletedNCT01006551Phase 2
- Comparison of the Efficacy and Safety of Risperidone Versus Risperidone Plus Low Dose of Haloperidol in the Treatment of SchizophreniaTerminatedNCT00998608Phase 4
- A Pharmacokinetic Study of Risperidone and Topiramate Administered Alone and in Combination in Patients With Bipolar Disorder or Schizoaffective DisordersCompletedNCT00986336Phase 1
- Quetiapine Extended Release (XR) for the Management of Psychotic Aggression or Agitation in Adult Acute PsychiatryStatus unknownNCT00986167Phase 4
- Quetiapine (Seroquel XR) for the Treatment of Fibromyalgia: a Clinical and Mechanistic Pilot StudyCompletedNCT00983320Phase 4
- Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)CompletedNCT00977301Phase 1
- Identification and Treatment Response Prediction of Antipsychotic-Related Metabolic SyndromeCompletedNCT00956189Not applicable
- A Double-blind, Randomized, Controlled Trial of Quetiapine Versus Haloperidol for the Treatment of DeliriumTerminatedNCT00954603Phase 3
- Quetiapine Prolong, Escitalopram and Hypothalamic-pituitary-adrenocortical (HPA) Axis Activity in Depressed PatientsCompletedNCT00953108Phase 3
- Lamictal TM, Haloperidol Decanoate in SchizophreniaTerminatedNCT00947375Phase 4
- To Demonstrate the Relative Bioequivalency of Generic Haloperidol Tablets Versus Haldol in Normal VolunteersCompletedNCT00946491Phase 1
- Bioequivalence Study of Risperidone 1 mg Tablets of Torrent Pharmaceuticals Limited, India and Risperdal® (Risperidone) 1 mg Tablets of Janssen Pharmaceutical Products, LP, USA, in Healthy Human Adult Subjects, Under Fed ConditionsCompletedNCT00939926Phase 1
- Bioequivalence Study of Risperidone 1.0 mg Tablets of Torrent Pharmaceuticals Limited., India and Risperdal® (Risperidone) 1.0 mg Tablets of Janssen Pharmaceutical Products, LP, USA, in Healthy Human Adult Subjects, Under Fasting ConditionsCompletedNCT00939497Phase 1
- Contrasting the Brain Effects of Risperidone and Invega With Functional Magnetic Resonance Imaging (fMRI) and Positron Emission Tomography (PET) ScanningStatus unknownNCT00937261Phase 4
- Use, Effects and Side-effects of Second-generation Antipsychotics in a Naturalistic SettingCompletedNCT00932529Phase 4
- Tardive Dyskinesia and Cognitive FunctionCompletedNCT00926965Phase 4
- Evaluate the Pharmacokinetics of Quetiapine Fumarate in Chinese Schizophrenic PatientsCompletedNCT00919607Phase 1
- Polypharmacy in Clozapine-resistant SchizophreniaCompletedNCT00918021Phase 4
- A Phase 4 Study to Evaluate Response to Treatment and Safety of Paliperidone Extended-Release in Participants With SchizophreniaCompletedNCT00915512Phase 4
- Quetiapine Augmentation for Primary Anxiety Disorder or Mood Disorders With Co-morbid Anxiety SymptomsCompletedNCT00912535Phase 4
- Metabolic Effects of Antipsychotic Substitution in ChildrenWithdrawnNCT00910780Phase 2/3
- Effect of Add-on Citalopram to Risperidone on Negative Symptoms in SchizophreniaCompletedNCT00893256Phase 4
- A Study of the Potential Effects of Trimethoprim on the Pharmacokinetics of ER OROS PaliperidoneCompletedNCT00892541Phase 1
- A Bioequivalence Study of 15 mg ER OROS PaliperidoneCompletedNCT00892489Phase 1
- Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive DisorderCompletedNCT00892463Phase 4
- A Study of the Effect of Food on the Pharmacokinetics of ER OROS Paliperidone in Healthy Japanese VolunteersCompletedNCT00892320Phase 1
- Staccato Loxapine Pulmonary Safety in Patients With AsthmaCompletedNCT00890175Phase 1
- Staccato Loxapine Pulmonary Safety in Patients With COPDCompletedNCT00889837Phase 1
- Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)TerminatedNCT00885690Not applicable
- Aripiprazole and Topiramate on Free-Choice Alcohol UseCompletedNCT00884884Phase 2/3
- Brain Derived Neurotrophic Factor as a Predictor of Response to Treatment in Bipolar Depression and Mania: 16-weeks Follow-up With Quetiapine XRStatus unknownNCT00879307Phase 3
- An Acceptability Study of Unflavored Asenapine Versus Raspberry Flavored Asenapine in Stable Patients With a Psychotic Disorder (P07010)(COMPLETED)CompletedNCT00878462Phase 2
- Olanzapine for the Treatment of Appetite Loss in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00876772Phase 2/3
- Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major DepressionCompletedNCT00873795Not applicable
- Staccato Loxapine PK in Smokers and NonsmokersCompletedNCT00873769Phase 1
- Quetiapine in Specific PhobiaCompletedNCT00872716Phase 2
- Sertindole in Asian Patients With SchizophreniaCompletedNCT00864045Phase 3
- Efficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in SchizophreniaCompletedNCT00859872Phase 4
- Risperidone Maintenance Treatment in SchizophreniaCompletedNCT00848432Phase 4
- Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar DisordersCompletedNCT00845988Phase 4
- Pilot Study to Evaluate the Efficacy and Safety of Quetiapine Fumarate Instant-Release (Seroquel IR) in Controlling Agitation and Aggressive Symptoms in the Acute Treatment of Patients With SchizophreniaStatus unknownNCT00838032Phase 4
- Aripiprazole for Neuroleptic-Induced Tardive DyskinesiaStatus unknownNCT00837707Phase 4
- A Study to Evaluate the Efficacy and Safety of Flexible Dose of Quetiapine Fumarate (Seroquel) Switching From Other Drugs in the Treatment of Acute Manic Patients With Bipolar DisorderStatus unknownNCT00837343Phase 4
- An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar DepressionCompletedNCT00835107Phase 4
- Haloperidol vs Olanzapine for the Management of ICU DeliriumTerminatedNCT00833300Not applicable